The equine asthma model of airway remodeling: from a veterinary to a human perspective
- 30 April 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell and tissue research
- Vol. 380 (2), 223-236
- https://doi.org/10.1007/s00441-019-03117-4
Abstract
Human asthma is a complex and heterogeneous disorder characterized by chronic inflammation, bronchospasm and airway remodeling. The latter is a major determinant of the structure-function relationship of the respiratory system and likely contributes to the progressive and accelerated decline in lung function observed in patients over time. Corticosteroids are the cornerstone of asthma treatment. While their action on inflammation and lung function is well characterized, their effect on remodeling remains largely unknown. An important hindrance to the study of airway remodeling as a major focus in asthma research is the lack of reliable non-invasive biomarkers. In consequence, the physiologic and clinical consequences of airway wall thickening and altered composition are not well understood. In this perspective, equine asthma provides a unique and ethical (non-terminal) preclinical model for hypothesis testing and generation. Severe equine asthma is a spontaneous disease affecting adult horses characterized by recurrent and reversible episodes of disease exacerbations. It is associated with bronchoalveolar neutrophilic inflammation, bronchospasm, and excessive mucus secretion. Severe equine asthma is also characterized by bronchial remodeling, which is only partially improved by prolonged period of disease remission induced by therapy or antigen avoidance strategies. This review will focus on the similarities and differences of airway remodeling in equine and human asthma, on the strengths and limitations of the equine model, and on the challenges the model has to face to keep up with human asthma research.Keywords
This publication has 130 references indexed in Scilit:
- Multiple secretoglobin 1A1 genes are differentially expressed in horsesBMC Genomics, 2012
- Elastin in asthmaPulmonary Pharmacology & Therapeutics, 2012
- Asthma outcomes: ExacerbationsJournal of Allergy and Clinical Immunology, 2012
- Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Human asthma phenotypes: from the clinic, to cytokines, and back againImmunological Reviews, 2011
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Bronchial hyper-responsiveness, subepithelial fibrosis, and transforming growth factor-β1 expression in patients with long-standing and recently diagnosed asthmaArchivum Immunologiae et Therapiae Experimentalis, 2008
- Assessment of bronchial wall thickness and lumen diameter in human adults using multi‐detector computed tomography: comparison with theoretical modelsJournal of Anatomy, 2007
- Bronchial matrix and inflammation respond to inhaled steroids despite ongoing allergen exposure in asthmaClinical and Experimental Allergy, 2005
- Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthmaJournal of Allergy and Clinical Immunology, 1999